Reviva Pharmaceuticals (RVPH) Projected to Post Quarterly Earnings on Monday

Chronological Source Flow
Back

AI Fusion Summary

Reviva Pharmaceuticals (RVPH) is expected to report Q4 2025 earnings of $‑0.0543 per share ahead of its earnings call on Monday, March 30, 2026. The stock trades near $0.80 with a market cap of $5.15 million.
#Reviva Pharmaceuticals #Q4 2025 earnings #earnings call #stock price #market capitalization #NASDAQ #analyst expectations #negative earnings
23/03 07:10 defenseworld.net
3 Πηγές

Reviva Pharmaceuticals (RVPH) Projected to Post Quarterly Earnings on Monday

Reviva PharmaceuticalsQ4 2025 earningsearnings callstock pricemarket capitalizationNASDAQ
23/03 07:42 defenseworld.net

Phio Pharmaceuticals (PHIO) Projected to Post Earnings on Monday

EARNINGS PREVIEWSPOLITICSCOMPANIES
23/03 08:28 defenseworld.net

Acumen Pharmaceuticals (ABOS) Projected to Post Earnings on Monday

POLITICSEARNINGS PREVIEWSCOMPANIES
Comments
Loading...
0